Cargando…

The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease

BACKGROUND: Numerous pre-clinical studies and clinical trials demonstrated that induction of antibodies to the β-amyloid peptide of 42 residues (Aβ(42)) elicits therapeutic effects in Alzheimer's disease (AD). However, an active vaccination strategy based on full length Aβ(42 )is currently hamp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davtyan, Hayk, Ghochikyan, Anahit, Cadagan, Richard, Zamarin, Dmitriy, Petrushina, Irina, Movsesyan, Nina, Martinez-Sobrido, Luis, Albrecht, Randy A, García-Sastre, Adolfo, Agadjanyan, Michael G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162512/ https://www.ncbi.nlm.nih.gov/pubmed/21806809 http://dx.doi.org/10.1186/1479-5876-9-127

Ejemplares similares

Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy
por: Movsesyan, Nina, et al.
Publicado: (2008)

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
por: Agadjanyan, Michael G., et al.
Publicado: (2017)

Alzheimer’s disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
por: Davtyan, Hayk, et al.
Publicado: (2016)

Mannan-Abeta(28 )conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice
por: Petrushina, Irina, et al.
Publicado: (2008)

Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein
por: Zagorski, Karen, et al.
Publicado: (2022)

Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer’s Disease
por: Zagorski, Karen, et al.
Publicado: (2023)

Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice
por: Davtyan, Hayk, et al.
Publicado: (2019)

A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice
por: Hovakimyan, Armine, et al.
Publicado: (2019)

Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2022)

Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies
por: Kim, Changyoun, et al.
Publicado: (2023)

Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials
por: Petrushina, Irina, et al.
Publicado: (2020)

Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer
por: Ghochikyan, Anahit, et al.
Publicado: (2014)

Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates
por: Hovakimyan, Armine, et al.
Publicado: (2022)

Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1
por: Zamarin, Dmitriy, et al.
Publicado: (2005)

A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors
por: Loukinov, Dmitri, et al.
Publicado: (2023)

Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins in vitro and in vivo
por: Nogales, Aitor, et al.
Publicado: (2019)

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2011)

Host- and Strain-Specific Regulation of Influenza Virus Polymerase Activity by Interacting Cellular Proteins
por: Bortz, Eric, et al.
Publicado: (2011)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Intercalated Nanocomposites Based on High-Temperature Superconducting Ceramics and Their Properties
por: Tonoyan, Anahit, et al.
Publicado: (2009)

Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data
por: Zamarin, Dmitriy, et al.
Publicado: (2015)

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
por: Nogales, Aitor, et al.
Publicado: (2022)

Understanding Immunology via Engineering Design: The Role of Mathematical Prototyping
por: Klinke, David J., et al.
Publicado: (2012)

Antimicrobial Resistance in a Tertiary Care Hospital in Armenia: 2016–2019
por: Davtyan, Hayk, et al.
Publicado: (2021)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
por: Liu, Ying L., et al.
Publicado: (2018)

Tuberculosis treatment and Smoking, Armenia, 2014–2016
por: Balian, Dikran Raffi, et al.
Publicado: (2017)

Dual deep modeling: multi-level modeling with dual potencies and its formalization in F-Logic
por: Neumayr, Bernd, et al.
Publicado: (2016)

CMS FPGA dual port memory prototypes
por: Gigi, D
Publicado: (1997)

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
por: Burman, Bharat, et al.
Publicado: (2020)

Female adipocyte androgen synthesis and the effects of insulin
por: Cadagan, David, et al.
Publicado: (2014)

Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein
por: Guerra, Susana, et al.
Publicado: (2011)

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge()
por: Klausberger, Miriam, et al.
Publicado: (2014)

The OBDT board: A prototype for the Phase 2 Drift Tubes on-detector electronics
por: Sastre Alvaro, Javier
Publicado: (2020)

Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer
por: Lam, Clarissa, et al.
Publicado: (2023)

236 SARS-coronavirus inhibits interferon induction both at pre- and post-transcriptional levels
por: Kuri, Thomas, et al.
Publicado: (2008)

Immunological imprinting of the antibody response in COVID-19 patients
por: Aydillo, Teresa, et al.
Publicado: (2021)

SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity
por: Manali, Maria, et al.
Publicado: (2022)

Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.
por: Rathnasinghe, Raveen, et al.
Publicado: (2021)

Discovery of a cryptic pocket in the AI-predicted structure of PPM1D phosphatase explains the binding site and potency of its allosteric inhibitors
por: Meller, Artur, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5gbkgjm6k4g3r4110hcv2vnlku